Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 29, 2024
Andelyn Biosciences, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selected to manufacture adeno-associated vectors (AAV) therapies in its suspension platform for several programs under the ...
read more
Wednesday, February 28, 2024
RRD International announced that it launched its new brand RRD Biopharma Development reflecting its unique offering of delivering strategy-driven product development services to biopharmaceutical companies and investors.
read more
Wednesday, February 28, 2024
Simtra BioPharma Solutions, a premier injectable contract development and manufacturing organization (CDMO), announced a $250+ million expansion of its sterile fill/finish manufacturing campus in Bloomington, Indiana.
read more
Tuesday, February 27, 2024
Viking Therapeutics, a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced positive top-line results from the company's Phase 2 clinical trial of VK2735, a dual ...
read more
Tuesday, February 27, 2024
Experic, a contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the biopharmaceutical industry, announced its new facility in Dublin, Ireland, to support global clinical trials.
read more
Tuesday, February 27, 2024
The artificial intelligence (AI) in drug discovery market is projected to reach USD 4.9 billion by 2028 from USD 900 million in 2023, at a CAGR of 40.2%
read more
Thursday, February 22, 2024
Immunocore Holdings announced that it has entered into a clinical trial collaboration and supply agreement with Bristol Myers Squibb to investigate Immunocore’s ImmTAC bispecific TCR (T cell receptor) candidate targeting PRAME HLA-A02, IMC-F106C, in ...
read more
Wednesday, February 21, 2024
Worldwide Clinical Trials has expanded the pharmacy at its Clinical Pharmacology Unit (CPU) in San Antonio, Texas. Completed in January 2024, the expanded pharmacy provides Worldwide’s customers with streamlined processes, as well as decreased ...
read more
Wednesday, February 21, 2024
Charles River Laboratories International, Inc. announced a strategic agreement with Wheeler Bio, Inc., an antibody contract development and manufacturing organization (CDMO) focused on preclinical and early clinical supply of recombinant proteins, ...
read more
Tuesday, February 20, 2024
AES Clean Technology, a leading provider of high-performance modular cleanroom facilities, has appointed Chris Barbieri as Vice President of Engineering.
read more
Tuesday, February 20, 2024
RSSL, a pharmaceutical contract research organization, has announced plans to launch its new Innovation Hub, a dedicated platform to help small- and medium-sized biotech organizations de-risk and accelerate the development of cutting-edge products.
read more
Tuesday, February 20, 2024
National Resilience, Inc. (Resilience) announced the expansion of the company’s clinical and commercial drug product manufacturing capabilities across its network. By scaling this capacity, Resilience aims to provide over 200 million units to its ...
read more
Friday, February 16, 2024
Catalyst Clinical Research announced that Nik Morton, the company's president and COO, assumed its CEO role on 12 February 2024. Mr. Morton joined Catalyst as its COO in 2022. Mr. Morton moved into his new position while Nick Dyer, Catalyst's former ...
read more
Friday, February 16, 2024
Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, announced the Aseptic Process Simulation (APS) qualification of its ...
read more
Wednesday, February 14, 2024
The PPD clinical research business of Thermo Fisher Scientific Inc., is adding mycoplasma and additional biosafety testing capabilities to its expanding portfolio of services at its good manufacturing practices (GMP) lab in Middleton, Wisconsin.
read more